Not suitable for anyone allergic to the ingredients
Providers should review medical history and test for relevant factors to reduce the risk of complications
Mediators of Inflammation, 2016, 3094642
Specifically, changing the Val229 residue to alanine, selected in this study for further investigation, was predicted to trigger a change in the cavity and a buried exposure switch at the inactive receptor, thereby potentially modifying the interactions between itself and other pocket residues with cholesterol
Woerther PL, Burdet C, Chachaty E, Andremont A (2013) Trends in human fecal carriage of extended-spectrum beta-lactamases in the community: toward the globalization of CTX-M
A meta-analysis by Simoneau M et al